tg6002
Biologicalexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Oct 12, 2017 (NCT03294486)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04194034 | Phase 1/Phase 2 (Phase 2) | Dec 31, 2019 | Transgene |
| NCT03724071 | Phase 1/Phase 2 (Phase 2) | Oct 16, 2018 | Transgene |
| NCT03294486 | Phase 1/Phase 2 (Phase 2) | Oct 12, 2017 | Assistance Publique - Hôpitaux de Paris, Transgene |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Transgene | For profit | 3 | 2 | 1 | 2017 |
| Assistance Publique - Hôpitaux de Paris | Academic/Hospital | 1 | 1 | 1 | 2017 |
2 organizations
Page 1 / 1